Provexis (PXS) Competitors

GBX 0.85 0.00 (0.00%)
As of 12:07 PM Eastern

PXS vs. VLG, ORPH, EAH, MRK, and DNL

Should you buy Provexis stock or one of its competitors? Provexis's main competitors and comparable companies include Venture Life Group (VLG), Open Orphan (ORPH), ECO Animal Health Group (EAH), Marks Electrical Group (MRK), and Diurnal Group (DNL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Provexis compare to Venture Life Group?

Provexis (LON:PXS) and Venture Life Group (LON:VLG) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk.

Provexis has a beta of 0.681, indicating that its share price is 32% less volatile than the broader market. Comparatively, Venture Life Group has a beta of 0.234, indicating that its share price is 77% less volatile than the broader market.

In the previous week, Provexis had 1 more articles in the media than Venture Life Group. MarketBeat recorded 1 mentions for Provexis and 0 mentions for Venture Life Group. Provexis' average media sentiment score of 0.00 equaled Venture Life Group'saverage media sentiment score.

Company Overall Sentiment
Provexis Neutral
Venture Life Group Neutral

Venture Life Group has a net margin of 17.42% compared to Provexis' net margin of -39.76%. Venture Life Group's return on equity of 7.82% beat Provexis' return on equity.

Company Net Margins Return on Equity Return on Assets
Provexis-39.76% -44.68% -56.14%
Venture Life Group 17.42%7.82%1.56%

7.9% of Provexis shares are held by institutional investors. Comparatively, 20.7% of Venture Life Group shares are held by institutional investors. 11.8% of Provexis shares are held by company insiders. Comparatively, 7.7% of Venture Life Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Venture Life Group has higher revenue and earnings than Provexis. Provexis is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Provexis£1.26M15.77-£619.15K-£0.02N/A
Venture Life Group£35.17M2.34£747.21K£4.3715.84

Summary

Venture Life Group beats Provexis on 8 of the 12 factors compared between the two stocks.

How does Provexis compare to Open Orphan?

Provexis (LON:PXS) and Open Orphan (LON:ORPH) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

Open Orphan has a net margin of 0.00% compared to Provexis' net margin of -39.76%. Open Orphan's return on equity of 0.00% beat Provexis' return on equity.

Company Net Margins Return on Equity Return on Assets
Provexis-39.76% -44.68% -56.14%
Open Orphan N/A N/A N/A

7.9% of Provexis shares are owned by institutional investors. 11.8% of Provexis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Provexis had 1 more articles in the media than Open Orphan. MarketBeat recorded 1 mentions for Provexis and 0 mentions for Open Orphan. Provexis' average media sentiment score of 0.00 equaled Open Orphan'saverage media sentiment score.

Company Overall Sentiment
Provexis Neutral
Open Orphan Neutral

Open Orphan has higher revenue and earnings than Provexis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Provexis£1.26M15.77-£619.15K-£0.02N/A
Open Orphan£34.71M0.00N/AN/AN/A

Summary

Open Orphan beats Provexis on 5 of the 8 factors compared between the two stocks.

How does Provexis compare to ECO Animal Health Group?

Provexis (LON:PXS) and ECO Animal Health Group (LON:EAH) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

ECO Animal Health Group has a net margin of 2.50% compared to Provexis' net margin of -39.76%. ECO Animal Health Group's return on equity of 2.55% beat Provexis' return on equity.

Company Net Margins Return on Equity Return on Assets
Provexis-39.76% -44.68% -56.14%
ECO Animal Health Group 2.50%2.55%2.14%

ECO Animal Health Group has higher revenue and earnings than Provexis. Provexis is trading at a lower price-to-earnings ratio than ECO Animal Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Provexis£1.26M15.77-£619.15K-£0.02N/A
ECO Animal Health Group£87.53M0.61£1.05M£3.1525.40

7.9% of Provexis shares are held by institutional investors. Comparatively, 40.9% of ECO Animal Health Group shares are held by institutional investors. 11.8% of Provexis shares are held by company insiders. Comparatively, 11.3% of ECO Animal Health Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

ECO Animal Health Group has a consensus target price of GBX 160, suggesting a potential upside of 99.95%. Given ECO Animal Health Group's stronger consensus rating and higher possible upside, analysts plainly believe ECO Animal Health Group is more favorable than Provexis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Provexis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
ECO Animal Health Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Provexis has a beta of 0.681, meaning that its stock price is 32% less volatile than the broader market. Comparatively, ECO Animal Health Group has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market.

In the previous week, Provexis and Provexis both had 1 articles in the media. Provexis' average media sentiment score of 0.00 equaled ECO Animal Health Group'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Provexis
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
ECO Animal Health Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

ECO Animal Health Group beats Provexis on 11 of the 14 factors compared between the two stocks.

How does Provexis compare to Marks Electrical Group?

Marks Electrical Group (LON:MRK) and Provexis (LON:PXS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.

7.1% of Marks Electrical Group shares are held by institutional investors. Comparatively, 7.9% of Provexis shares are held by institutional investors. 75.4% of Marks Electrical Group shares are held by insiders. Comparatively, 11.8% of Provexis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Provexis had 1 more articles in the media than Marks Electrical Group. MarketBeat recorded 1 mentions for Provexis and 0 mentions for Marks Electrical Group. Marks Electrical Group's average media sentiment score of 0.00 equaled Provexis'average media sentiment score.

Company Overall Sentiment
Marks Electrical Group Neutral
Provexis Neutral

Marks Electrical Group has a beta of 0.577, suggesting that its stock price is 42% less volatile than the broader market. Comparatively, Provexis has a beta of 0.681, suggesting that its stock price is 32% less volatile than the broader market.

Marks Electrical Group has a net margin of -0.39% compared to Provexis' net margin of -39.76%. Marks Electrical Group's return on equity of -4.18% beat Provexis' return on equity.

Company Net Margins Return on Equity Return on Assets
Marks Electrical Group-0.39% -4.18% 0.91%
Provexis -39.76%-44.68%-56.14%

Marks Electrical Group has higher revenue and earnings than Provexis. Marks Electrical Group is trading at a lower price-to-earnings ratio than Provexis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Marks Electrical Group£107.93M0.45£426.93K-£0.40N/A
Provexis£1.26M15.77-£619.15K-£0.02N/A

Marks Electrical Group currently has a consensus target price of GBX 52.50, suggesting a potential upside of 11.70%. Given Marks Electrical Group's stronger consensus rating and higher possible upside, analysts plainly believe Marks Electrical Group is more favorable than Provexis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Marks Electrical Group
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Provexis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Marks Electrical Group beats Provexis on 9 of the 15 factors compared between the two stocks.

How does Provexis compare to Diurnal Group?

Diurnal Group (LON:DNL) and Provexis (LON:PXS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

Diurnal Group has a net margin of 0.00% compared to Provexis' net margin of -39.76%. Diurnal Group's return on equity of 0.00% beat Provexis' return on equity.

Company Net Margins Return on Equity Return on Assets
Diurnal GroupN/A N/A N/A
Provexis -39.76%-44.68%-56.14%

Diurnal Group has higher revenue and earnings than Provexis. Provexis is trading at a lower price-to-earnings ratio than Diurnal Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Diurnal Group£4.68M0.00N/A-£8.50N/A
Provexis£1.26M15.77-£619.15K-£0.02N/A

7.9% of Provexis shares are held by institutional investors. 11.8% of Provexis shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Provexis had 1 more articles in the media than Diurnal Group. MarketBeat recorded 1 mentions for Provexis and 0 mentions for Diurnal Group. Diurnal Group's average media sentiment score of 0.00 equaled Provexis'average media sentiment score.

Company Overall Sentiment
Diurnal Group Neutral
Provexis Neutral

Summary

Diurnal Group beats Provexis on 5 of the 9 factors compared between the two stocks.

Get Provexis News Delivered to You Automatically

Sign up to receive the latest news and ratings for PXS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PXS vs. The Competition

MetricProvexisPharmaceuticals IndustryHealthcare SectorLON Exchange
Market Cap£19.94M£13.61B£7.74B£2.79B
Dividend Yield5.06%2.58%2.46%5.11%
P/E Ratio-42.5029.4134.1723.17
Price / Sales15.777.028.485.10
Price / CashN/A15.7421.9320.23
Price / Book99.095.114.372.48
Net Income-£619.15K£2.88B£3.52B£5.88B
7 Day Performance-7.61%-4.11%-5.47%-1.22%
1 Month Performance-5.56%-5.09%-4.58%-2.86%
1 Year Performance44.56%-7.45%-1.79%6.43%

Provexis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PXS
Provexis
N/AGBX 0.85
flat
N/A+48.6%£19.94M£1.26MN/A4
VLG
Venture Life Group
N/AGBX 69
flat
N/A+15.2%£82.02M£35.17M15.79165
ORPH
Open Orphan
N/AN/AN/AN/A£67.09M£34.71MN/A179
EAH
ECO Animal Health Group
2.1778 of 5 stars
GBX 87
+4.2%
GBX 160
+83.9%
-5.9%£58.05M£87.53M27.62234
MRK
Marks Electrical Group
0.6289 of 5 stars
GBX 50
+3.1%
GBX 52.50
+5.0%
+2.2%£52.02M£107.93MN/A200

Related Companies and Tools


This page (LON:PXS) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners